During the past decade, Nova Clinical Research, LLC conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 7 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 6 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nova Clinical Research, LLC" #1 sponsor was "Bayer" with 3 trials, followed by "Celgene" with 3 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Supernus Pharmaceuticals, Inc." with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nova Clinical Research, LLC" #1 collaborator was "Solstice Neurosciences" with 2 trials as a collaborator, "CoLucid Pharmaceuticals" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Nova Clinical Research, LLC" are "Crohn Disease" (3 trials), "Heart Failure" (2 trials), "Multiple Sclerosis" (2 trials), "Parkinson Disease" (2 trials) and "Spasticity" (2 trials). Many other conditions were trialed in "Nova Clinical Research, LLC" in a lesser frequency.

Most popular intervention types in "Nova Clinical Research, LLC" are "Drug" (20 trials), "Other" (5 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Ozanimod" (3 trials), "Guselkumab Dose 1" (2 trials), "Guselkumab Dose 2" (2 trials) and "Guselkumab Dose 3" (2 trials). Other intervention names were less common.

The vast majority of trials in "Nova Clinical Research, LLC" are 22 trials for "All" genders.

Currently, there are NaN active trials in "Nova Clinical Research, LLC". undefined are not yet recruiting, 7 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Nova Clinical Research, LLC, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Nova Clinical Research, LLC, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".